The Sarcoma Biology and Outcome Project

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12+
SponsorProf. Dr. Richard F Schlenk

About this trial

SarcBOP - An interdisciplinary and translational registry

SarcBOP aims to establish a database that integrates every aspect possibly relevant to sarcoma treatment and research. SarcBOP thus will not be limited to specific questions or patient groups, but instead will build a comprehensive database including clinical, pathologic, and radiologic information, multi-layered molecular data, and patient-reported outcomes, combined with a dedicated biobank for tissue samples and liquid biopsies. As the study integrates seamlessly with the clinical activities of the Heidelberg Sarcoma Center, the Molecular Diagnostics Program of NCT Heidelberg, including the NCT/DKTK MASTER Program, and with the NCT Trial Center, including the PMO Clinical Trials Program, SarcBOP will generate a comprehensive and continuously growing resource for clinicians, researchers, and, finally, patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Suspected or proven diagnosis of soft-tissue or bone sarcoma (STBS)

Age ≥12 years

Ability to understand nature and individual consequences of the registry

Written informed consent

Disqualifiers

None

Trial population

Patients with Soft-tissue and Bone Sarcoma

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

overall survival

The length of time from the date of diagnosis disease, that patients diagnosed with are still alive

Time frame
5 years
2

overall survival

The length of time from the date of diagnosis disease, that patients diagnosed

Time frame
10 years

Secondary outcomes

1

progression free survival

length of time during and after treatment, that a Patient lives with the disease without getting worse

Time frame
5 years

Other outcomes

1

Core questionnaire QLQ-C30

Standardized Quality of Life Assessment, Higher values are better

Time frame
5 years
2

Fatigue module QLQ-FA12

Standardized Quality of Fatigue, Higher values are worse

Time frame
5 years
3

PHQ-4 (anxiety and depression)

Standardized Quality of anxiety and depression, Higher values are worse

Time frame
5 years
4

FACT-cog (cognitive function)

Standardized Quality of cognitive function, Higher values are better

Time frame
5 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Prof. Dr. Richard F Schlenk

Lead sponsor

University Hospital Heidelberg

Sponsor institution